Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,728,505 papers from all fields of science
Search
Sign In
Create Free Account
cifenline
Known as:
2-(2,2-diphenylcyclopropyl)-2-imidazoline
, cibenzoline
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (2)
Anti-Arrhythmia Agents
Imidazoles
Narrower (2)
Cipralan
cifenline succinate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Antiarrhythmic drug cibenzoline attenuates left ventricular pressure gradient and improves transmitral Doppler flow pattern in patients with hypertrophic obstructive cardiomyopathy caused by…
M. Hamada
,
Y. Shigematsu
,
+7 authors
J. Higaki
Circulation Journal
2005
Corpus ID: 38255376
BACKGROUND Recent interventional and surgical therapies to attenuate left ventricular pressure gradient (LVPG) can be difficult…
Expand
2004
2004
Beneficial effect of cibenzoline on left ventricular pressure gradient with sigmoid septum.
Chika Konishi
,
J. Shiraishi
,
+5 authors
H. Matsubara
Circulation Journal
2004
Corpus ID: 23324322
An 83-year-old woman with hypertension was admitted to hospital with episodes of dyspnea on effort after having breakfast…
Expand
1998
1998
The antiarrhythmic agent cibenzoline inhibits KATP channels by binding to Kir6.2.
E. Mukai
,
H. Ishida
,
M. Horie
,
A. Noma
,
Y. Seino
,
M. Takano
Biochemical and Biophysical Research…
1998
Corpus ID: 32788209
We reported previously that cibenzoline, an antiarrhythmic agent, inhibits the ATP-sensitive K+ (KATP) channels of pancreatic…
Expand
1993
1993
Inhibition of the ATP‐sensitive potassium channel by class I antiarrhythmic agent, cibenzoline, in rat pancreatic β‐cells
M. Kakei
,
M. Nakazaki
,
T. Kamisaki
,
Issei Nagayama
,
Yuzou Fukamachi
,
Hiromitsu Tanaka
British Journal of Pharmacology
1993
Corpus ID: 21325412
1 Cibenzoline, a class I antiarrhythmic agent, was investigated for its effect on the ATP‐sensitive K+ channel of pancreatic…
Expand
1993
1993
Antiarrhythmic drugs, clofilium and cibenzoline are potent inhibitors of glibenclamide‐sensitive K+ currents in Xenopus oocytes
H. Sakuta
,
K. Okamoto
,
Yasuhiro Watanabe
British Journal of Pharmacology
1993
Corpus ID: 25797841
1 The novel K+ channel opener, Y‐26763 induced outward K+ currents in voltage‐clamped follicle‐enclosed Xenopus oocytes in a…
Expand
1991
1991
Comparison of Ca2+ channel inhibitory effects of cibenzoline with verapamil on guinea-pig heart.
S. Matsuoka
,
T. Nawada
,
+4 authors
H. Mashiba
General Pharmacology
1991
Corpus ID: 4929766
1986
1986
Inhibition of the myocardial Ca2+ inward current by the class 1 antiarrhythmic agent, cibenzoline
M. Hoick
,
W. Osterrieder
British Journal of Pharmacology
1986
Corpus ID: 43028153
1 Cibenzoline, a class 1 (local anaesthetic‐type) antiarrhythmic drug, was investigated for possible effects upon the myocardial…
Expand
1984
1984
Effects of cibenzoline, a novel antiarrhythmic drug, on action potential and transmembrane currents in frog atrial muscle.
C. Massé
,
M. Cazes
,
A. Sassine
Archives internationales de pharmacodynamie et de…
1984
Corpus ID: 43824858
The mechanisms of action of cibenzoline upon the electrical activity of the cardiac membrane in vitro, were studied using frog…
Expand
1983
1983
Pharmacological mapping of regional effects in the rabbit heart of some new antiarrhythmic drugs
J. Millar
,
E. Willams
British Journal of Pharmacology
1983
Corpus ID: 21301262
1 In vitro preparations of rabbit heart were made from which measurements of effective refractory period (ERP), atrio‐Hisian (A‐H…
Expand
Highly Cited
1982
Highly Cited
1982
EFFECTS ON RABBIT NODAL, ATRIAL, VENTRICULAR AND PURKINJE CELL POTENTIALS OF A NEW ANTIARRHYTHMIC DRUG, CIBENZOLINE, WHICH PROTECTS AGAINST ACTION POTENTIAL SHORTENING IN HYPOXIA
J. Millar
,
E. Williams
British Journal of Pharmacology
1982
Corpus ID: 26028435
1 The effects of cibenzoline (UP 339–01), a new anti‐arrhythmic drug, have been investigated in various cardiac tissues. 2 UP 339…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE